Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. OKYO.L Share Price
  4. OKYO.L Share Regulatory News
  5. ADS Program collapse

Pin to quick picksOKYO.L Regulatory News (OKYO)

OKYO.L Information
  • There is currently no data for OKYO

ADS Program collapse

19 May 2023 08:00

RNS Number : 9540Z
OKYO Pharma Limited
19 May 2023
 

 

OKYO PHARMA LIMITED

ADS Program collapse - Commencement of trading of new ordinary shares on The Nasdaq Capital Market

LONDON and NEW YORK, May 19, 2023 -- OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO) hereby announces that following the implementation of the share capital consolidation and collapse of its ADS program, it is expected that new OKYO ordinary shares will be listed on The Nasdaq Capital Market with effect from the opening of business in New York on Monday May, 22, 2023.

OKYO has been listed on The Nasdaq Capital Market via an ADS since May 17 2022. OYKO announced its intention to delist from the London Stock Exchange plc on April 2, 2023 and on May 3, 2023 shareholders passed the necessary resolutions to consolidate its existing ordinary shares by a 65 into 1 reverse split (thereby matching the current ADS ratio of 65 ordinary shares comprised in each ADS). Each new OKYO ordinary share will accordingly represent 65 of the old ordinary shares and be equal to one ADS.

The CUSIP for the new OKYO ordinary shares is G6724L116 and the ISIN is GG00BMFG5F62.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEAKSPFSNDEFA
1234567
Date   Source Headline
19th Mar 20207:00 amRNSPlacing to raise £560,000
2nd Mar 202011:50 amRNSResult of AGM
19th Dec 20197:00 amRNSDirectorate Change
29th Nov 20197:00 amRNSHalf-year Report
28th Aug 20197:00 amRNSChemerin Update
19th Aug 20197:00 amRNSCollaboration with Prof. Pedram Hamrah
30th Jul 20192:05 pmRNSSecond Price Monitoring Extn
30th Jul 20192:00 pmRNSPrice Monitoring Extension
1st Jul 20197:00 amRNSFinal Results
30th May 20192:52 pmRNSHolding(s) in Company
20th May 201910:58 amRNSResult of General Meeting
26th Apr 20197:00 amRNSSubscription and Waiver
25th Apr 20195:30 pmRNSHolding(s) in Company
7th Mar 20197:00 amRNSPresentation of Preclinical Data
23rd Jan 20197:00 amRNSCorporate Update
30th Nov 20184:06 pmRNSHalf-year Report
1st Nov 20187:00 amRNSExpected Admission Date for Consideration Shares
24th Oct 20187:00 amRNSAllotment of Ordinary Shares & Listing Application
21st Sep 20187:00 amRNSAppointment of Senior R&D Director
6th Sep 201812:38 pmRNSResult of AGM
22nd Aug 201812:13 pmRNSHolding(s) in Company
21st Aug 201812:09 pmRNSAnnual Report and Notice of AGM
31st Jul 20186:05 pmRNSFinal Results
9th Mar 201811:01 amRNSResult of General Meeting and Corporate Update
2nd Mar 201812:47 pmRNSChange of Broker
21st Feb 20185:00 pmRNSSuspension - Okyo Pharma Corporation
21st Feb 20185:00 pmRNSProposed cancellation, suspension, notice of GM
2nd Feb 20181:17 pmRNSChange of Name and Corporate Update
10th Jan 201811:14 amRNSResult of General Meeting
4th Jan 20189:52 amRNSIssue of Equity, Directors' Dealing
21st Dec 201710:40 amRNSProposed Disposal, Special Dividend, Notice of GM
18th Dec 201712:23 pmRNSInterim Report for Period Ended 30 September 2017
13th Nov 20174:12 pmRNSBoard Changes and Corporate Update
29th Sep 20177:00 amRNSReport and Accounts for year to 31 March 2017
6th Jul 20171:47 pmRNSBoard Appointment
16th Jun 20171:18 pmRNSHolding(s) in Company
8th Jun 20175:07 pmRNSHolding(s) in Company
5th Jun 20177:00 amRNSDirectorate Change
12th May 20177:00 amRNSScoping Study
22nd Dec 201612:34 pmRNSHalf-year Report
29th Sep 20165:50 pmRNSAnnual Financial Report
12th Aug 20167:00 amRNSChange of Broker
1st Apr 201612:44 pmRNSBoard Changes and Corporate Update
11th Feb 20167:00 amRNSDirector's Dealing
22nd Dec 20157:00 amRNSHalf Yearly Report
29th Sep 20153:45 pmRNSAnnual Financial Report
21st Aug 20154:37 pmRNSCorporate Update
27th Jul 20157:00 amRNSDirectors' dealing
2nd Jun 20157:00 amRNSBoard changes and withdrawal of requisition
29th Apr 201512:15 pmRNSRequisition of General Meeting - Update
1234567

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
JDS
JDS.L
LSE
0.00%
DFI
Dfi Retail Intl
LSE
0.00%
OXB
Oxford Biomedica
LSE
5.00%
STHY
Pim Ushy Usd In
LSE
-0.22%
DFCH
Distrib. Fin.
LSE
0.93%
Trending
SBTX
Skinbiotherap.
LSE
0.00%
PLE
Plethora Solutions Holdings Plc
LSE
0.00%
CMET
Capital Metals
LSE
-0.97%
ALRT
Defence Holdings
LSE
19.05%
IMM
Immupharma
LSE
-2.26%